期刊文献+

星点设计效应面优化法优化三七总皂苷鼻腔用粉雾剂 被引量:24

Optimization of the intranasal powders of Panax Notoginseng Saponins by the central composite design-response surface methodology
下载PDF
导出
摘要 目的确定三七总皂苷鼻腔用粉雾剂的较优处方。方法以人参皂苷Rb11h、12h和人参皂苷Rg11h、12h的累积释放度、制剂的生物粘附强度及蟾蜍上腭黏膜纤毛毒性为指标,采用星点设计效应面优化法,确定较优处方。结果当三七总皂苷、微晶纤维素和中等粘度羟丙基纤维素的比例分别为31、60和9时,Rb11h、12h和Rg11h、12h的累积释放度分别为6.82、53.25和83.47、95.09,生物粘附强度为78min,蟾蜍上腭黏膜纤毛持续运动时间为为生理盐水组的94.84,几乎没有纤毛毒性。结论应用星点设计效应面优化法能够快速方便地得到三七总皂苷鼻腔用粉雾剂的较优处方。 AIM: To determine the optimized intranasal powders formulation of Panax Notoginseng Saponins(PNS). METHODS: According to the indexes of the in vitro release rate in 1h and 12h of Rb1 and Rg1, bioadhesive intensity and the ciliary toxicity in situtoad palatal mucosa of the preparations, the optimized formulation was determined by the central composite design-response surface methodology. RESULTS: When the correspondent percentage of PNS, microcrystalline cellulose (MCC) and moderate viscosity hydroxypropyl cellulose (H-HPC) was 31%, 60% and 9%, respectively, the release rate in 1h and 12h of Rb1 and Rg1 was 6.82%, 53.25% and 83.4%, 95.09%, respectively. The adhesive time was 78min, and the lasting time of ciliary movement after the rinsing of the PNS powders was 94.84% to the physiological saline group which suggested the powder was almost no toxicity. CONCLUSIONS: The optimized formulation of the PNS intranasal powder was obtained quickly and conveniently by the central composite design-response surface methodology.
出处 《中成药》 CAS CSCD 北大核心 2005年第1期10-15,共6页 Chinese Traditional Patent Medicine
关键词 三七总皂苷 释放度 生物粘附强度 纤毛毒性 星点设计-效应面优化法 Panax Notoginseng Saponins the release rate bioadhesive intensity the ciliary toxicity the central composite design-response surface methodology
  • 引文网络
  • 相关文献

参考文献6

二级参考文献32

共引文献611

同被引文献430

引证文献24

二级引证文献470

;
使用帮助 返回顶部